Corneal & Ocular Surface Regeneration Research
Beyond artificial tears, advancing true recovery.
As Korea’s first advanced regenerative medicine institution in ophthalmology, we are leading the way.
For patients with Sjögren’s syndrome and chronic,
treatment-resistant dry eye disease
-
[MSC & Exosome-Based Anti-Inflammatory Regenerative Therapy Research]
-
-
Cell Sourcing: Securing clinically validated mesenchymal stem cell (MSC) lines.
-
High-Efficiency Culturing: Cultured under specialized conditions to maximize anti-inflammatory and regenerative factor secretion.
-
Active Component Purification: High-purity extraction and concentration of key regenerative components, including exosomes and growth factors.
-
Therapeutic Application: Optimized treatment delivered as eye drops or localized administration, tailored to each patient’s condition.